Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding
- PMID: 7128007
- DOI: 10.1038/clpt.1982.218
Effects of cancer and its treatments on plasma concentration of alpha 1-acid glycoprotein and propranolol binding
Abstract
The plasma concentrations of alpha 1-acid glycoprotein (AAG) and albumin, and the plasma protein binding of propranolol were measured in a group of cancer patients and a group of normal subjects. In cancer patients the AAG concentrations were twice that in controls (142 and 78 mg/dl, P less than 0.005), the albumin concentrations were lower (3.11 and 4.37 gm/dl, P less than 0.001), and the free fraction of propranolol was lower (0.127 and 0.190, P less than 0.005). Propranolol binding correlated strongly with AAG concentrations. These data imply that untreated or unsuccessfully treated cancer patients will have reduced free fractions for any drug for which AAG is an important binding protein. Successfully treated patients may have longitudinal changes towards normal. No consistent effect of the treatments themselves on AAG was observed after radiation therapy in five patients or after intravenous adriamycin in six patients.
Similar articles
-
Binding of prazosin and propranolol at variable alpha 1-acid glycoprotein and albumin concentrations.Br J Clin Pharmacol. 1989 Feb;27(2):229-34. doi: 10.1111/j.1365-2125.1989.tb05355.x. Br J Clin Pharmacol. 1989. PMID: 2713217 Free PMC article.
-
Alpha 1-acid glycoprotein concentrations and propranolol binding in elderly patients with acute illness.Br J Clin Pharmacol. 1984 Nov;18(5):806-10. doi: 10.1111/j.1365-2125.1984.tb02548.x. Br J Clin Pharmacol. 1984. PMID: 6508990 Free PMC article.
-
Methadone plasma protein binding: alterations in cancer and displacement from alpha 1-acid glycoprotein.Clin Pharmacol Ther. 1982 Nov;32(5):652-8. doi: 10.1038/clpt.1982.217. Clin Pharmacol Ther. 1982. PMID: 7128006
-
Human alpha-1-glycoprotein and its interactions with drugs.Drug Metab Rev. 2001 May;33(2):161-235. doi: 10.1081/dmr-100104402. Drug Metab Rev. 2001. PMID: 11495502 Review.
-
Determination of human serum alpha1-acid glycoprotein and albumin binding of various marketed and preclinical kinase inhibitors.Curr Med Chem. 2009;16(16):1964-77. doi: 10.2174/092986709788682191. Curr Med Chem. 2009. PMID: 19519376 Review.
Cited by
-
Influence of menstrual cycle phase on serum concentrations of alpha 1-acid glycoprotein.Br J Clin Pharmacol. 1991 Feb;31(2):197-9. doi: 10.1111/j.1365-2125.1991.tb05515.x. Br J Clin Pharmacol. 1991. PMID: 2049238 Free PMC article.
-
Construction of 2DE Patterns of Plasma Proteins: Aspect of Potential Tumor Markers.Int J Mol Sci. 2022 Sep 21;23(19):11113. doi: 10.3390/ijms231911113. Int J Mol Sci. 2022. PMID: 36232415 Free PMC article.
-
Effect of age and sex on the plasma binding of acidic and basic drugs.Eur J Clin Pharmacol. 1984;27(1):91-7. Eur J Clin Pharmacol. 1984. PMID: 6489431
-
Melphalan concentration dependent plasma protein binding in healthy humans and rats.Eur J Clin Pharmacol. 1987;32(2):179-85. doi: 10.1007/BF00542192. Eur J Clin Pharmacol. 1987. PMID: 3582482
-
Variation in serum binding of tertatolol mediated by disease-induced modification of alpha-acid glycoprotein concentration.Eur J Clin Pharmacol. 1988;34(4):381-5. doi: 10.1007/BF00542440. Eur J Clin Pharmacol. 1988. PMID: 2900145
MeSH terms
Substances
LinkOut - more resources
Full Text Sources